🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

22 recruiting trials

for Cardio-Oncology

EXERT-BC Cardio: Cardio or Conditioning Training With Breast Cancer NCT07739563NA1 site📍 Pittsburgh Allegheny Singer Research Institute (also known as Alleghen… · Tests: Resistance Training with Cardio, Resistance Training with Conditioning JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First Year NCT06930521NA1 site📍 Toronto Women's College Hospital · Tests: Intervention - Low Risk Group OR Intermediate Risk Group High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe) NCT07223385Phase 21 site📍 Los Angeles Cedars-Sinai Medical Center · Tests: Cardio-Oncology Referral, Notification to PCP/General Cardiologist Exercise Phenotyping Prior to Chemotherapy in Newly Diagnosed Multiple Myeloma (MM-Exercise) NCT07851493n/a1 site📍 Munich Technical University of Munich Cardio-Oncology Rehabilitation Care Process NCT06302634n/a1 site📍 Santiago de Compostela Hospital Clinico Universitario de Santiago · Tests: Exercise-based cardio-oncology rehabilitation The Effectiveness of Astaxanthin Supplementation on the Clinical Symptoms and Cardio-metabolic Profile in Women with Polycystic Ovary Syndrome NCT06642363Phase 11 site📍 Isfahan Isfahan University of Medical Sciences · Tests: Subjects in the intervention group will receive one capsule containing 10 mg Astaper day made by the "Zyest Techno… Cardio-Oncology Rehabilitation in Breast Cancer Patients Undergoing Chemotherapy NCT07823660NA1 site📍 Porto Alegre Hospital de Clinicas de Porto Alegre · Tests: Cardio-Oncology Exercise Rehabilitation Program Cardio-Oncology Registry NCT04407780n/a1 site📍 Paris European Georges Pompidou Hospital · Tests: No interventions are planned RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast Cancer NCT05256745Phase 1, Phase 23 sites📍 Washington D.C.📍 Washington D.C.📍 Hackensack Georgetown University · Tests: TTP488, ddAC/ddT, TC, TCHP, Chemotherapy regimen that includes ddAC Prehabilitation Program to Improve Cardiac Reserve in High-Risk Patients Undergoing Hematopoietic Stem Cell Transplantation NCT05945121NA1 site📍 Ann Arbor University of Michigan Rogel Cancer Center · Tests: Cardio-oncology program Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial) NCT03711110NA14 sites📍 Santiago de Compostela📍 Galdakao📍 Barcelona Fundación Instituto de Estudios de Ciencias de la Salud de … · Tests: Intensive cardiovascular monitoring, No intervention Cardiac Side Effects of Systemic Therapy in Early-Stage Breast Cancer NCT07588425n/a1 site📍 Ankara Fatih GURLER Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care NCT03882580n/a3 sites📍 Paris📍 Paris📍 Paris Groupe Hospitalier Pitie-Salpetriere · Tests: Anti-Cancer Agents Global Cardio Oncology Registry NCT05598879n/a1 site📍 Weston The Cleveland Clinic · Tests: anonymized data collection during programmed surveillance clinical follow up Physical Activity and Healthy Aging: Promoting Cardio-metabolic Capacity to Fight Chronic Inflammation and Improve Outcomes in Breast Cancer Patients (PhActHealth Study) NCT07776951NA2 sites📍 Milan📍 Urbino University of Milan · Tests: Pre-habilitation exercise program ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies NCT07191730n/a1 site📍 Caen University Hospital, Caen Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer Patients NCT05732051Phase 21 site📍 Lørenskog University Hospital, Akershus · Tests: Nicotinamide Riboside, Placebo Use of Dapagliflozin in Primary Prevention of Cardiotoxicity of Anthracycline Chemotherapy in Breast Cancer Patients NCT07245069Phase 21 site📍 Ljubljana University Medical Centre Ljubljana · Tests: Dapagliflozin 10 mg, Placebo Glasgow Low-dose CT and AI-based Diagnostics to Case Find Lung Cancer and Other Cardio-respiratory Long-term Conditions - Feasibility Study NCT07372508NA1 site📍 Glasgow NHS Greater Glasgow and Clyde · Tests: Low dose Chest CT Evaluation and Management of Cardio Toxicity in Oncologic Patients NCT02818517n/a1 site📍 Tel Aviv Tel-Aviv Sourasky Medical Center · Tests: ACE inhibitors, beta blockers Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM) NCT05465031Phase 44 sites📍 Opole📍 Gliwice📍 Zabrze Silesian Centre for Heart Diseases · Tests: Sacubitril-valsartan, Placebo Cardio-Oncology Rehabilitation Exercise NCT05522959n/a1 site📍 Toronto University of Toronto
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy